HyperClear: Solución láser para la hiperplasia benigna de próstata

HyperClear: Solución láser para la hiperplasia benigna de próstata

Un avanzado sistema láser diseñado para tratar la hiperplasia benigna de próstata (HBP) con precisión, proporcionando una eliminación eficaz del tejido, una mejora del flujo urinario y un tiempo de inactividad mínimo para mejorar los resultados del paciente.

Información

HyperClear represents an innovative laser therapy system designed to effectively remove surplus prostatic tissue in benign prostatic hyperplasia (BPH). Leveraging the LIFE (Laser-Induced Fiber Enucleation) method, HyperClear applies precise laser energy via a flexible fiber placed transurethrally to the obstructive zone, ablating the excess prostate tissue responsible for lower urinary tract symptoms (LUTS). This approach may be performed outpatient—often with local anesthesia—enhancing patient comfort while maintaining efficacy and safety.

High-Precision Laser Fiber
  • Optimized Energy Delivery: The laser fiber is advanced through the urethra to the blocked area, targeting surplus prostate tissue while minimizing collateral damage.
  • LIFE Method: Focused on selective tissue vaporization or enucleation, ensuring clean resection planes and predictable tissue removal.
  • Local Anesthesia: Allows many patients to undergo the procedure without the risks or recovery times associated with general anesthesia.
  • Rapid Recovery: Less invasive than conventional transurethral resections, potentially reducing hospital stays and improving patient throughput.
  • Precise Tissue Identification: Endoscopic imaging guides the laser fiber to the obstructive tissue, ensuring thorough clearance of the prostatic urethra.
  • Controlled Ablation: The surgeon can finely tune laser energy to match the tissue’s vascularity and density, limiting the risk of deep thermal damage.
  • Targeted Laser Ablation: Precisely removes hyperplastic prostate segments that hinder urine flow, preserving healthy tissue zones.
  • Hemostatic Effect: Laser energy also cauterizes small vessels during tissue vaporization, reducing intraoperative bleeding.

Clinical Advantages & Applications

Benign Prostatic Hyperplasia (BPH)
  • Symptomatic Relief: Alleviates classic LUTS such as frequent urination, weak urine stream, and prolonged emptying times.
  • Patient Selection: Suited for patients with moderate-to-severe BPH who seek a less invasive alternative to standard TURP or open prostatectomy.
  • Outpatient Possibility: Potentially performed under local anesthesia, minimizing hospitalization and facilitating early mobilization.
  • Lower Bleeding Risk: Laser-based enucleation or vaporization significantly reduces hemorrhage compared to mechanical resection methods.
  • Shorter Convalescence: Many patients resume daily activities sooner, with less postoperative discomfort or catheterization durations.
  • Reduced Need for General Anesthesia: Local or spinal anesthesia lessens systemic risks, beneficial for older or comorbid patients.

Especificaciones técnicas

Especificación Detalle / Valor
Nombre del producto Placas CytroFIX® Superior Clavicula
Material High-Purity Titanium Alloy (e.g., Ti-6Al-4V ELI)
Perfil de la placa Low-profile, contoured for superior clavicle placement
Mecanismo de bloqueo Locking or non-locking titanium screws; optional variable-angle locking
Diámetro del tornillo 2.7 mm or 3.5 mm (titanium cortical screws, depending on hole specification)
Espesor de la placa ~2.0–2.5 mm (minimized profile)
Hole Array Multiple holes for bridging, compression, or combined fixation patterns
Radiopacidad Titanium visible on fluoroscopy (optional etched markers)
Esterilidad Provided non-sterile (autoclavable) or sterile, single use or reusable instrumentation (verify product line)
Vida útil Indefinite if stored properly; reusable within recommended inspection cycles
Indicaciones clínicas Midshaft/lateral clavicle fractures requiring superior plating, osteotomies, nonunion correction
Cumplimiento de la normativa Conforms to ISO 13485, CE/FDA (region-specific), meets orthopedic implant standards

Matriz de tallas y pedidos

Longitud de la placa (mm) Recuento de agujeros Curvature Tornillo compatible Código del producto Notas
60 4 Mild Superior Bend 2,7 mm Bloqueo/no bloqueo CFX-SCL-60-4-27-Ti Shorter plate for smaller fractures in lateral or mid-shaft
70 5 Mild Superior Bend 2,7 mm Bloqueo/no bloqueo CFX-SCL-70-5-27-Ti Cobertura ampliada para fracturas de leves a moderadas
80 5 Moderate Superior Bend 2,7 o 3,5 mm Bloqueo CFX-SCL-80-5-MX-Ti Bridges midshaft fractures with variable-angle options
90 6 Moderate Superior Bend 3,5 mm Bloqueo/no bloqueo CFX-SCL-90-6-35-Ti For larger or multi-fragment fractures requiring robust support
100 7 Enhanced Superior Contour 3,5 mm Bloqueo/no bloqueo CFX-SCL-100-7-35-Ti Accommodates more complex or extended fracture lines
110 8 Enhanced Superior Contour 3,5 mm Bloqueo/no bloqueo CFX-SCL-110-8-35-Ti Longest plate design for challenging multi-segment fractures

Productos relacionados